Tg Therapeutics TGTX
NASDAQ TGTX
$54.29 +0.67 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2011 - 2012)

Updated

Tg Therapeutics (TGTX) recorded Income from Non-Controlling Interests of -$8.11 million in FY2012, compared with -$35,997 in FY2011.

Analysis

Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2011 - 2012) Analysis & Trends

  • Per Business Quant data, TGTX's Income from Non-Controlling Interests was -$35,997 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Tg Therapeutics 8.31 Bn 7.70 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -247,962.00
Jun 30, 2012 -679,506.00
Mar 31, 2012 -7.14 Mn
Dec 31, 2011 -19,592.00
Sep 30, 2011 -1,510.00
Jun 30, 2011 -14,895.00
API Access

Tg Therapeutics Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TGTX&period=max&api_key=YOUR_API_KEY